Nouscom
54 employees
Biotech/Pharma
Series C · $152.0M
Open positions (1)
Company details
Team Size54
IndustryBiotech/Pharma
Funding
Total raised
$152.0M
Last stage
Series C
Investors
M Ventures
Total raised
$152.0M
Last stage
Series C
Investors
Riccardo Cortese
Italian scientist and entrepreneur; founder of genetic vaccine company Okairos (acquired by GSK in 2013) and co-founder of Nouscom in 2015. Passed away in April 2017.
Alfredo Nicosia
Co-founder and former CEO of Nouscom; previously CSO and co-founder of Okairos. Led preclinical and clinical development of vaccines and monoclonal antibodies.
Cinzia Traboni
Co-founder of Nouscom; previously Head of Regulatory Affairs at Okairos, supporting clinical trials in cancer immunotherapy in the US and EU.
No applications, no recruiter spam. Just the intro.
A few questions to make sure this role is the right shape for you. Two minutes.
I write the intro, send it to the founder, and handle the back-and-forth.
If they’re a yes, I book the chat. You show up — that’s the whole job-hunt.